Navalign LLC’s Zimmer Biomet ZBH Stock Holding History

Navalign LLC’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-444	Closed	-$39.9K	–	494
2025 Q4	$39.9K	Buy	+444	New	+$42.1K	0.01%	207

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Navalign LLC's ZBH Position: Q1 2026 in Review

Navalign LLC sold out of Zimmer Biomet (ZBH) in Q1 2026, closing a stake of 444 shares — an estimated $39.9K sold.

Navalign LLC first reported a position in ZBH in Q4 2025 and held it in 1 quarter. The position peaked at $39.9K in Q4 2025. 914 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

Navalign LLC reported no remaining Zimmer Biomet position as of Q1 2026 after selling out during the quarter.
Navalign LLC sold 444 Zimmer Biomet shares in Q1 2026, an estimated $39.9K.
Navalign LLC first reported a position in Zimmer Biomet in Q4 2025 and held it in 1 quarter.
Navalign LLC's Zimmer Biomet position peaked at $39.9K in Q4 2025.
914 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Navalign LLC's 13F filing for Q1 2026, filed 29 Apr 2026.